At 8.7% CAGR, the Europe Swine Diagnostics Market is Projected to be worth US$ 109.26 million by 2030, says Business Market Insights

According to Business Market Insights research, the Europe swine diagnostics market was valued at US$ 56.05 million in 2022 and is expected to reach US$ 109.26 million by 2030, registering a CAGR of 8.7% from 2022 to 2030. Favorable government initiatives and increasing prevalence of swine diseases are among the critical factors attributed to the Europe swine diagnostics market expansion.               

Infectious diseases cause loss of production ability in farm animals. Governments across the world are emphasizing on making pig farmers aware of the most common and disastrous infectious diseases by undertaking initiatives to promote screening or mass diagnosis of these diseases. They are working with domestic and international companies to promote animal health products. These initiatives help convey the significance of livestock diagnosis to decision-makers, regulatory agencies, reference laboratories, and other end users.  

On the contrary, high costs involved in pork health maintenance hurdles the growth of Europe industrial robotics market.

Based on product type, the Europe swine diagnostics market is segmented into immunoassays kits, PCR kits, hemagglutination inhibition (HI), and others. The immunoassays kits segment held 43.6% share of Europe swine diagnostics market in 2022, amassing US$ 24.44 million. It is projected to garner US$ 50.12 million by 2030 to expand at 9.4% CAGR during 2022–2030.

Based on sample type, the Europe swine diagnostics market is segmented into blood, oral fluids, nasal swabs, tissue samples, and others. The blood segment held 40.0% share of Europe swine diagnostics market in 2022, amassing US$ 22.45 million. It is projected to garner US$ 46.70 million by 2030 to expand at 9.6% CAGR during 2022–2030.

Based on disease, the Europe swine diagnostics market is segmented into African swine fever (ASF)/classical swine fever (CSF), respiratory diseases, porcine circovirus, porcine epidemic diarrhea, swine dysentery, and others. The African swine fever (ASF)/classical swine fever (CSF) segment held 32.6% share of Europe swine diagnostics market in 2022, amassing US$ 18.27 million. It is projected to garner US$ 36.60 million by 2030 to expand at 9.1% CAGR during 2022–2030.  

Based on end user, the Europe swine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end users. The veterinary hospitals segment held 61.0% share of Europe swine diagnostics market in 2022, amassing US$ 34.18 million. It is projected to garner US$ 67.77 million by 2030 to expand at 8.9% CAGR during 2022–2030.

Based on country, the Europe swine diagnostics market is segmented into Germany, Spain, France, Italy, the UK, and the Rest of Europe. Our regional analysis states that Germany captured 26.5% share of Europe swine diagnostics market in 2022. It was assessed at US$ 14.87 million in 2022 and is likely to hit US$ 29.46 million by 2030, exhibiting a CAGR of 8.9% during 2022–2030.  

Key players operating in the Europe swine diagnostics market are BioCheck BV, Bionote Inc, Idexx Laboratories Inc, INDICAL BIOSCIENCE GmbH, Innovative Diagnostics SAS, Neogen Corp, Ring Biotechnology Co Ltd, SAN Group GmbH, Thermo Fisher Scientific Inc, and Zoetis Inc, among others.                                            

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com